FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091308 [Registered on: 21/07/2025] Trial Registered Prospectively
Last Modified On: 18/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of two medications used to increase blood pressure, phenylephrine and norepinephrine, on contraction of uterus after caesarean delivery 
Scientific Title of Study   Effect of prophylactic infusions of phenylephrine and norepinephrine on uterine contractility and uterotonic requirements during elective caesarean section under spinal anaesthesia: A randomised double-blind comparison 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Medha Mohta 
Designation  Director Professor and Head 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital  
Address  Department of Anaesthesiology and Critical Care University College of Medical Sciences and Guru Teg Bahadur Hospital

East
DELHI
110095
India 
Phone  9868399626  
Fax    
Email  mmohta@ucms.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Medha Mohta 
Designation  Director Professor and Head 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital  
Address  Department of Anaesthesiology and Critical Care University College of Medical Sciences and Guru Teg Bahadur Hospital


DELHI
110095
India 
Phone  9868399626  
Fax    
Email  mmohta@ucms.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Surbhi 
Designation  Post-graduate student 
Affiliation  University College of Medical Sciences and Guru Teg Bahadur Hospital  
Address  Department of Anaesthesiology and Critical Care University College of Medical Sciences and Guru Teg Bahadur Hospital

East
DELHI
110095
India 
Phone  8826643157  
Fax    
Email  surbhisauran007@gmail.com  
 
Source of Monetary or Material Support  
University College of Medical Sciences and GTB Hospital, Dilshad Garden, Delhi-110095  
 
Primary Sponsor  
Name  University College of Medical Sciences and Guru Teg Bahadur Hospital  
Address  University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi-110095  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Medha Mohta  University College of Medical Sciences and Guru Teg bahadur Hospital  Department of Anaesthesiology and Critical Care, 2nd Floor OT Block
East
DELHI 
9868399626

mmohta@ucms.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee - Human Research, University College of Medical Sciences, University of Delhi, Delhi -110095  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 1||Obstetrics, (2) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Norepinephrine infusion  Norepinephrine infusion will be started immediately after spinal anaesthesia and infusion rates will be titrated based on maternal systolic blood pressure 
Comparator Agent  Phenylephrine infusion  Phenylephrine infusion will be started immediately after spinal anaesthesia and infusion rates will be titrated based on maternal systolic blood pressure 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Consenting healthy mothers with term, uncomplicated, singleton pregnancy scheduled to undergo elective caesarean section under spinal anaesthesia 
 
ExclusionCriteria 
Details  History suggestive of maternal complications e.g., pre-eclampsia, cardiovascular disease, cerebrovascular disease
Known risk factors for postpartum haemorrhage e.g., multiple gestation, abnormal placentation, uterine fibroid, macrosomia, hydramnios, history of postpartum haemorrhage or uterine atony
Patients on monoamine oxidase inhibitors or tricyclic antidepressants
History suggestive of presence of mesenteric or peripheral vascular thrombosis
Patients with absolute or relative contra-indications for spinal anaesthesia
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Total oxytocin dose requirement  Intraoperative and 24 hours postoperative 
 
Secondary Outcome  
Outcome  TimePoints 
Adequacy of uterine tone
Additional uterotonics used
Estimated blood loss
Fall in haemoglobin
Side effects of vasopressors and oxytocin
Incidence of postpartum haemorrhage
 
Intraoperative and 24 hours postoperative 
 
Target Sample Size   Total Sample Size="130"
Sample Size from India="130" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   05/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This randomized, double-blind study will compare the effect of phenylephrine and norepinephrine on uterine contractility and uterotonic requirements during caesarean section in healthy consenting mothers with uncomplicated singleton, term pregnancy.  One hundred and thirty consenting mothers undergoing caesarean section under spinal anaesthesia will be studied. After administration of spinal anaesthesia, phenylephrine or norepinephrine infusion will be titrated to maintain blood pressure. Oxytocin will be administered post-delivery, with dose adjustments and rescue uterotonics as needed. Oxytocin dose requirement, adequacy of uterine tone, additional uterotonics requirements, estimated blood loss, change in haemoglobin, incidence of postpartum haemorrhage and any side effects will be assessed. Intraoperative monitoring and postoperative follow-up for 24 hours will be conducted. Primary outcome will be oxytocin dose requirements.
 
Close